Back/Quest Resource Holding: Leadership Transition at Sonora Quest Laboratories Promises Innovation Continuity
leadership·January 18, 2026·qrhc

Quest Resource Holding: Leadership Transition at Sonora Quest Laboratories Promises Innovation Continuity

ED
Editorial
Cashu Markets·2 min read
TL;DR
  • Jennifer Erickson will succeed David Dexter as CEO of Sonora Quest Laboratories, ensuring continuity in leadership.
  • Sonora Quest emphasizes innovation and community health through partnerships, enhancing access to diagnostic services.
  • Erickson aims to advance patient-centered diagnostics, building on the foundation established by Dexter's leadership.

Leadership Transition at Sonora Quest Laboratories Signals Continuity in Innovation

Sonora Quest Laboratories announces the appointment of Jennifer Erickson as Chief Executive Officer-Elect, succeeding long-time leader David Dexter, who will retire on March 31, 2026. With over 26 years at the helm, Dexter has transformed Sonora Quest into Arizona's preeminent clinical laboratory testing provider, conducting over 100 million diagnostic tests annually. His tenure is marked by pioneering initiatives such as the My Lab ReQuest™ direct-access testing platform launched in 2015 and the rapid expansion of COVID-19 testing through Operation Catapult in 2020. These innovations reflect not only the company’s adaptability but also its commitment to enhancing patient care and accessibility in diagnostics.

Erickson brings a wealth of experience to her new role, having previously served as CFO of Sonora Quest from 1999 to 2004. Her extensive background in health care and consumer services positions her well to uphold the company's legacy while steering it toward future growth. With a strong focus on patient-centered diagnostics, Erickson aims to further advance the company’s initiatives and strengthen its partnerships within the health care community. Her recent experience as CFO and COO at Clin-Path Associates/Pathology Specialists of Arizona has equipped her with the critical skills necessary to navigate the evolving landscape of clinical testing and patient care.

As Dexter transitions out of his leadership role, he expresses confidence in Erickson's capabilities, underscoring their long-standing mentor-mentee relationship developed over 26 years. Dexter emphasizes the importance of maintaining a culture of collaboration and accountability, values that are central to Sonora Quest's operations. As the company prepares for this leadership change, stakeholders anticipate that Erickson will build on the solid foundation established under Dexter's guidance, ensuring that Sonora Quest continues to lead in innovation and excellence in laboratory services.

In related developments, Sonora Quest Laboratories has reinforced its commitment to community health through partnerships with organizations like the American Cancer Society and CommunityCares. These collaborations have been instrumental in extending the reach of essential diagnostic services, particularly in underserved areas.

As the industry continues to evolve, the strategic leadership of Sonora Quest under Erickson's guidance is expected to play a crucial role in navigating challenges and capitalizing on emerging opportunities in the health care sector. This transition marks a pivotal moment for the company, as it seeks to maintain its leadership position while adapting to new health care demands.